TOKELAU
TOKELAU
FDA import refusal data for products from TOKELAU
Top Firms
| # | Firm Name | Risk | Refusals |
|---|---|---|---|
| 1 | MERCK SHARP DOHME PHARMACEUTICAL Istanbul | Risk: 39.0 | 1 |
| 2 | NOVATECH TIBBI CIHAZ URUNLERI SA Gaziantep | Risk: 36.7 | 1 |
| 3 | MSD DANISMANLIK TURIZM Basaksehir | Risk: 40.3 | 1 |
| 4 | Mahmut Yarim Gida Sanayi Ltd Antakya | Risk: 16.3 | 1 |
| 5 | Glaxosmithkline Ilac Tic Istanbul | Risk: 40.3 | 1 |
Frequently Asked Questions
How many FDA import refusals are from TOKELAU?
According to FDA records, there have been 5 import refusals for products originating from TOKELAU, involving 5 firms.
What products from TOKELAU are commonly refused by the FDA?
Products from TOKELAU may be refused for various reasons including adulteration, misbranding, lack of proper registration, or failure to meet U.S. safety standards. The specific products vary by firm and time period. View the common violations section on this page for more details.
Does an import refusal mean products from TOKELAU are unsafe?
Not necessarily. An import refusal indicates a specific shipment appeared to violate FDA requirements at the time of inspection. Many TOKELAU firms successfully import products that meet all FDA requirements. Import refusals help identify and prevent non-compliant products from entering the U.S. market.
How current is the FDA import refusal data for TOKELAU?
Our database includes FDA import refusals for TOKELAU through 9/6/2022. Data is sourced from the FDA Data Dashboard and updated monthly.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.